Literature DB >> 6765518

Receptor binding properties of human insulin (recombinant DNA) and human proinsulin and their interaction at the receptor site.

R Prager, G Schernthaner.   

Abstract

The binding properties of human insulin (recombinant DNA) and human proinsulin were compared in seven healthy volunteers. Specific cell binding of human proinsulin was significantly lower compared with the human insulin receptor binding with an approximately 100-fold lower average affinity (3.71 mol-1 X 10(8) for human insulin versus 0.042 mol-1 X 10(8) for human proinsulin). Native human proinsulin at low concentrations had no significant effect on specific human insulin receptor binding. Only at high hormone concentrations human proinsulin could displace human insulin from the insulin receptor. We conclude that in vivo proinsulin-insulin interactions at the receptor do not possess major clinical relevance.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6765518     DOI: 10.2337/diacare.5.2.s104

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  3 in total

Review 1.  New roles of carboxypeptidase E in endocrine and neural function and cancer.

Authors:  Niamh X Cawley; William C Wetsel; Saravana R K Murthy; Joshua J Park; Karel Pacak; Y Peng Loh
Journal:  Endocr Rev       Date:  2012-03-07       Impact factor: 19.871

2.  Endocytotic uptake, processing, and retroendocytosis of human biosynthetic proinsulin by rat fibroblasts transfected with the human insulin receptor gene.

Authors:  J R Levy; A Ullrich; J M Olefsky
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

3.  Decreased insulin receptor binding in hyperthyroidism.

Authors:  G Schernthaner; R Prager; M Weissel; R Höfer
Journal:  Klin Wochenschr       Date:  1984-11-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.